← Leaderboards
Kazusa Ishii
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Chimeric Antigen Receptor T Cells”
- James L Riley · University Of Pennsylvania$30,820,107
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$26,234,170
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$21,497,910
- Michael A Caligiuri · Ohio State University$20,843,639
- Luis J. Montaner · Wistar Institute$20,061,975
- Crystal Mackall · Children'S Hosp Of Philadelphia$19,988,621
Research focus
Chimeric Antigen Receptor T CellsT-Cell ReceptorScienceToxic EffectLeukemia/LymphomaHematologic NeoplasmsPre-ClinicalSafetyT Cell TherapyT-LymphocyteEarly Phase Clinical TrialImmunotherapeutic AgentLeukemiaCd22 GeneB Lymphoid MalignancyAntigensCancer CellClinical TranslationAntigen TargetingLegal PatentInterestClinically RelevantHematological DiseaseCollaborations
Grant awards (5)
TCR engineered T cell therapies for hematologic malignancies$535,786
ZIA · FY2025 · CA · contact PI
TCR engineered T cell therapies for hematologic malignancies$657,016
ZIA · FY2024 · CA · contact PI
TCR engineered T cell therapies for hematologic malignancies$628,503
ZIA · FY2023 · CA · contact PI
TCR engineered T cell therapies for hematologic malignancies$701,185
ZIA · FY2022 · CA · contact PI
TCR engineered T cell therapies for hematologic malignancies$733,139
ZIA · FY2021 · CA · contact PI